Evafact 2 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Evafact 2 mg Tablet contains dienogest, a synthetic progestin similar to a natural female hormone. Its labelling describes it for the treatment of pelvic pain associated with endometriosis, by controlling the growth of endometrial tissue and lowering estradiol levels in the body. It is described as taken once daily on a continuous basis, including during menstruation.
Product Information
The following description reflects information associated with dienogest and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of pelvic pain associated with endometriosis
- Described as helping with painful menstruation (dysmenorrhoea) and pain during or after sexual intercourse
- Described as controlling the growth of endometrial tissue and lowering estradiol levels
Described Dosage & Administration
- Taken by mouth regularly, as advised by the doctor, who sets the dose according to symptoms
- Taken continuously, including during menstrual periods
- A missed dose should be taken as soon as it is remembered; treatment should not be stopped without asking the doctor
Described Side Effects
Commonly described side effects include:
- Acne
- Headache
- Low or depressed mood
- Breast discomfort
- Nausea
- Ovarian cysts
- Changes to the menstrual cycle, spotting, or brown discharge
Changes to bleeding patterns are described as common; if they continue, the doctor should be consulted. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any previous vaginal or uterine bleeding or any circulatory blood disorder
- The doctor should be told about all other medicines being taken, as they may alter the result
- The doctor should be informed if the patient is pregnant, planning a pregnancy, or breastfeeding
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains dienogest, a synthetic progestin used to treat pelvic pain associated with endometriosis by controlling endometrial tissue growth and lowering estradiol levels. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth regularly at the dose set by the doctor, continuously and including during menstrual periods. A missed dose should be taken when remembered, and treatment should not be stopped without asking the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.